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Abstract
PDI, protein disulfide isomerase, is one of the most versatile proteins and highly expressed in
mammalian cells because there is a vast number of proteins that must undergo processing before
secretion to their final destinations. PDI has several functions: oxidation of nascent proteins and
isomerization of existing disulfide bonds. It also possesses chaperone activity and participates in
protein degradation. Because of its structure, PDI can exist in a reduced or oxidized form. In
mammalian cells it is mostly reduced due to the high demand of disulfide bond shuffling of
secreted proteins within the ER, PDI a, a’, and b’ posses the ability to facilitate substrate folding.
In our experiments we are using rat PDI and according to the sequence there are cysteine
residues located in a and a’ domains. These cysteine residues may contribute to the catalytic
activity of this domain and will be analyzed in future studies.

Misfolded proteins, and the

associated endoplasmic reticulum (ER) stress, are emerging as hallmarks of age- and
neurodegeneration-related disorders such as Huntington’s disease (HD), Alzheimer’s disease
(AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis. Recent and compelling
evidence has linked nitrosative stress and the ER-resident oxidoreductase, protein disulfide
isomerase (PDI), to the pathogenesis of PD and AD. Overexpression of PDI has been found to
reduce the formation of polyubiquitinated proteins, making the oxidoreductase an important
target for therapeutic intervention in PD, AD and other age- and neurodegeneration-related
disorders. We demonstrate the NO-scavenging ability of the biphenolic natural products
curcumin and masoprocol and the concomitant prevention of S-nitrosylation of PDI by a model
NO-donor. Furthermore, both ethnopharmaceuticals accelerate protein fold acquisition in their
neat and nitrated forms, making them attractive candidates for prevention of age- and
neurodegeneration-related diseases.

xiv

Chapter 1: Introduction
Protein Disulfide Isomerase (PDI)
What is PDI?
Protein disulfide isomerase (PDI), a very abundant protein in the endoplasmic reticulum of the
cell, facilitates the formation and rearrangement of disulfide bonds using two nonequivalent
redox active-sites, located in two different thioredoxin homology domains. Each dithiol/disulfide
active-site contains the thioredoxin consensus sequence CXXC. Four domains of protein
disulfide isomerase were constructed that contain only a single active-site cysteine. Kinetic
analysis of these mutants show that the first (more N-terminal) cysteine in either active site is
indispensable for catalysis of oxidation and rearrangement during the refolding of reduced
bovine pancreatic ribonuclease A (RNase A). [1][2] PDI was first isolated from liver in 1963 by
the pioneer of protein folding, Christian Anfinsen and characterized depending on its ability to
catalyze the refolding of ribonuclease A, an enzyme with 4-disulfide bridges. The protein-thiol
oxidoreductase activity of PDI appears to differ based upon the redox environment and cellular
requirements. [3]

General functions of PDI
PDI catalyzes the formation of disulfide bonds and isomerizes incorrect disulfide in the nascent
polypeptides undergoing folding in the oxidizing environment of the endoplasmic reticulum. The
bulk of PDI is localized to the ER, consistent with a signal sequence and an ER retention signal.
But the availability of PDI has been shown on the plasma membrane as well as in the cytosol,
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endosome and at the plasma membrane, where PDI reduces disulfide bridges of proteins in as an
upshot of the more reducing environments of those locales. Although PDI was initially
characterized as an oxidoreductase, it is now known as a multifunctional contributor in the
folding, assembly and post-translational modification of many proteins. It displays chaperone
and anti-chaperone activities in vitro and in vivo (Cai et al., 1994; Primm et al., 1996; Puig and
Gilbert, 1994b). In Saccharomyces cerevisiae, PDI is an indispensable protein (Scherens et al.,
1991) and its crucial role in this organism is to catalygize disulfide bond formation (Solovyov et
al., 2004; Xiao et al., 2004). PDI is also a subunit of two well characterized ER enzymes, proly 4
hydroxylase (P4H) (Pihlajaniemi et al., 1987) and microsomal triglyceride transfer protein
(MTP) (Wetterau et al., 1990). [4][5][6]

PDI structure
PDI is a member of the thioredoxin superfamily. The multidomain nature of PDI was initially
recognized from an analysis of its amino acid sequences, in which four domains, denoted a, b, b’
and a’ were identified. These structural domains are followed by an extended acidic residue at
the C terminus (designated c) (Edman et al., 1985). Proteolytic mapping and heterologous
expression of individual domains established and refined the domain boundaries of PDI (Darby
et al., 1996) (Fig.1). [6] a and a’ domains are homologous to each other (47% identity) and to
thioredoxin (27% identity). Each of these domains contains an active site CGHC motif that can
be reduced mammalian thioredoxin reductase, which further support a close structural
relationship to thioredoxin (Lundstrom and Holmgren, 1990). In isolation, the PDI-a domain
behaves as a folded globular protein in both its dithio and disulfide forms (Darby and Creighton,
1995b), and the structure of the disulfide form has been shown by NMR analysis to be very

2

similar to that of thioredoxin (Kemmink et al., 1996). On the other hand, the PDI-a’ domain is
less stable than expected, as it unfolds at least partly upon formation of its disulfide bond (Darby
and Creigton et al., 1995b). The b and b’ have similar sequences (28% identity), but show or
very low sequence relatedness to thioredoxin and do not contain symbolic CGHC motif.

↓

(A)
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(B)

Fig.1. The structure of mammalian PDI. (A) Domain boundaries have been determined by a
combination of protein engineering and limited proteolysis studies (Darby et al., 1996). The first
and last residues of each folded structure are indicated. The c domain at the C- terminus
comprises a 24 acidic segment followed by KDEL sequence for retention in the endoplasmic
reticulum. (B)Three dimensional structure of PDI

Fig.2. Electrostatic surface representation of the structures of the individual PDI domains. The
structures of a and b are from NMR determinations. The arrow denotes the nucleophilic active
site cysteine. The top and bottom rows represent 180 degree rotations of each domain around the
4

horizontal. The b’ and a’ structures are homology models and should be considered as such. The
anionic c domain is arbitrarily shown in an extended conformation.
Although a high resolution X-ray crystal structure of PDI has not been determined, the NMR
structures of the isolated a and b domains provided the first detailed structural information about
PDI. [7][8]. The a domain of PDI, as expected from its primary structure homology, has a
thioredoxin fold with all the secondary structural elements of thioredoxin and two grooves that
are sites of enzyme-substrate interaction (Kemmink et al., 1996). Surprisingly, NMR studies of
the b domain of PDI indicates that like a domain, the b domain also has a thioredoxin fold
despite the absence of any CXXC redox active sites or sequence similarity to thioredoxin
(kemmink et al., 1997). Sequence homology between the b and b’ and a and a’ imply that PDI
consists of four tandem domains with thioredoxin structure. [9] The c domain has been defined
as the region 465 to the C terminus of the PDI polypeptide. This region of PDI may not be an
actual domain as there is no evidence of defined secondary or tertiary structure. However, the c
domain is of considerably interest because of its high content of acidic residues and the presence
of the C terminal KDEL retention signal. The C-terminal KDEL motif of the PDI polypeptide is
involved in the ER localization of the enzyme (Pelham, 1990). The acidic residues of the c
domain participate in the extensive calcium binding activity of PDI (Lebeche et al., 1994).
Although there is no structure data on the entire PDI molecule, sedimentation velocity and
equilibrium measurements suggest that PDI is an elongated monomer with an axial ratio of ~5,
consistent with nearly linear arrangement of the domains (Solovyov and Gilbert, 2004). [10][11]
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Peptide binding
The ability to interact with polypeptides and unfolded proteins is the foundation for the activity
of a chaperone and perhaps equally important for the activity of a disulfide isomerase. The most
striking feature of the wild-ranging catalytic activities of PDI is its ability to catalyze steps in
protein folding pathways which involve significant conformational change in protein substrate,
associated with protein disulfide bond formation or isomerization. Full length PDI is much more
effective than the individual a and a’ domains as a catalyst for such steps in the folding pathway
of reduced RNase (Darby et al., 1998a), although the isolated domains are equally effective as
catalysts of simple thiol-disulfide interchange reaction (Darby and Creighton, 1995b). This
suggests that the complex natural substrate of PDI make extensive contacts with the PDI
molecule, which may facilitate transactions between different conformational states of the
protein substrate. [12] Peptide binding studies using either somatostatin or a 28-residue peptide
from the N-terminus of staphylococcal nuclease indicate that the interaction of peptides with PDI
competes with the refolding of reduced, denatured RNase and scrambled RNase, reduces the
efficiency of catalysis of insulin reduction, inhibits the chaperone function of PDI in the
refolding of denatured Glyceraldehyde 3-phosphate dehydrogenase (Klqappa et al., 1997;
Morjana and Gilbert, 1991; Quan et al., 1995). This indicates not only that both peptide and
polypeptide binding sites are the same or spatially juxtaposed, but also that they are close enough
to the active site to inhibit the redox activity when occupied by a polypeptide chain. PDI interact
weekly (KD>100 µM) with polypeptide (Morjana and Gilbert, 1991). [36][37] The binding
increases with increasing length of substrate backbone, but for peptides of similar length, those
containing cysteine residues bind 4-8 folds more strongly to PDI (Klappa et al., 1997; Morjana
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and Gilbert, 1991). The hydrophobic interaction may determine the efficiency of binding. Photo
affinity labeling studies with a radioactive tripeptide probe have localized the first peptidebinding site that begins at the end of a’ and includes most of domain c (Noiva et al., 1993).
[38][39][40] Deletion of extreme C-terminal helix of domain a’ has an inhibitory effect on the
assembly of recombinant proly-4 hydroxylase in insect cells or on the in vitro chaperone activity
or disulfide isomerase activity of PDI (Koivunen et al., 1999).The mutations in the C-terminal
part of a’ domain can also affect the peptide binding activity of PDI, a function associated with
b’ domain (Klappa et al., 2000). [41] Using a cross-linking method, Klappa and colleagues has
demonstrated that b’ domain of PDI provides the principal peptide-binding site of PDI. The b’a’c
construct is the smallest fragment that is able to bind a large misfolded protein as well as small
peptides and a’ domain contributes more to the binding of full length PDI than does the a domain
(Klappa et al., 1998a). [13][14][15]

Ribonuclease A
Before describing the products of the artificial oligomerisation of bovine pancreatic ribonuclease
A, a short description of some of the main features of RNase A is appropriate. The enzyme
which is one of the most studied proteins in the world is composed of 124 amino acids
(molecular mass, 13,686 Da), among which basic residues (10 Lys, 4 Arg, besides 4 His) prevail
over acidic residues (5 Glu, 5 Asp), making therefore the protein definitely basic, with a pI of
9.3. The protein’s secondary structure consists of three α-helices and seven β-strands, and the
molecule contains four disulphide bonds (26-84, 40-95, 58-110, 65-72) (Fig.2) that definitely
contribute, in particular the two terminal ones (26-84 and 58-110), to the remarkable stability of
the protein. It might be worth pointing out that RNase A, in contrast with many other proteins
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with disulphide bridges, has rather long termini outside the disulphide-bonded core, in which the
two active-site histidines (His-12 and His-119) are indeed located. The N-terminus (residues 115), comprising one of the α-helices (residues 3-13), is connected with the body of the protein by
a flexible loop (residues 16-23) that, under controlled conditions, may be cleaved by subtilisin
forming RNase S, without any loss of activity. The C-terminal β-hairpin of RNase A is
composed by two β-strands (residues 105-124) relatively richer in hydrophobic residues than the
N-terminus. Both termini can become mobile under defined experimental conditions that weaken
the noncovalent bonds between them and the protein core. The protein can be viewed as a kidney
bean whose two main lobes are separated by a positively charged region which binds the RNA
substrate. [42][43][44] We just mention here some details concerning its enzymatic activity that
can be useful in the further discussion, referring the interested reader to the many excellent
reviews available for more detailed information concerning the structural and functional
properties of RNaseA. The active site of the enzyme is formed by His-12, His-119 and Lys-41.
The well-known “in line” mechanism of the endonucleolytic cleavage of single-stranded RNA
by RNase A consists of a first transesterification step (leading to 2’, 3’-cyclic phosphate
intermediates), and a following hydrolytic action on these intermediates. To take place the
reaction requires that the 2’ oxygen of the ribose hydroxyl group, which acts as an internal
nucleophile, and the 5’ oxygen leaving group simultaneously occupy the two apical positions
within the trigonal bipyramidal phosphorane intermediate. This steric requirement makes a
fruitful interaction of the enzyme with double stranded RNA impossible, and therefore it is
chiefly responsible for the high resistance of this RNA species to attack by native, monomeric
RNase A. It must be remembered, however, that other variables, such as the ionic strength and
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the presence of carbohydrate chains on the enzyme protein, influence the resistance of doublehelical RNA to ribonuclease attack. [16][17][89]

Fig.3. A ribbon diagram of RNase A with the disulfide bonds highlighted by spheres. The
disulfide bonds 26–84 and 58 –110 are completely buried, whereas disulfide bonds 40–95 and
65–72 are partially exposed (Koradi et al., 1996)

Oxidative folding of RNaseA
Bovine pancreatic ribonuclease A (RNase A) is ideally suited for elucidating the oxidative
protein folding events because RNase A contains disulfide bonds, and its folding has been
studied in depth. The protein consists of 124 amino acid residues and contains four
intramolecular disulfide bonds (26-84, 40-95, 58-110 and 65-72). Recent studies in our
laboratory involve DTTox/DTTred-coupled refolding experiments using 2 aminoethyl
methanethiosulfonate (AEMTS) as a rapid thiol-blocking agent. The use of DTTox/DTTred
instead of the commonly used GSSG/GSH as the redox reagent significantly simplifies proteinfolding studies because the number of possible disulfide-bonded intermediates is drastically
reduced, from 7191 to 762, by eliminating the formation of mixed disulfide bonds (Rothwarf &
Scheraga, 1993a). [91][92][93]
The oxidative folding of the four-disulfide protein bovine pancreatic ribonuclease A (RNase A)
by DTTox is done at 25°C and pH 8, the native protein is regenerated from the fully reduced
form through two major (Rothwarf et al., 1998a, b) and two minor (Iwaoka et al., 1998; Xu and
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Scheraga, 1998) pathways, involving the formation of two intermediate three-disulfide species,
des-[65–72] and des-[40 –95]4, which have native- like structures (Shimotakahara et al., 1997;
Laity et al., 1997). [18][45]

R

1S

2S

3S

4S

3S* [Des [40-95] Des [65-72] ]

N

Fig.4. A model for the regeneration of native protein from reduced RNase A with DTTox at 25°C
and pH 8.0. R represents the fully reduced protein, nS represents an ensemble of species with n
disulfide bonds
These two intermediates, which appear in the rate-determining step from the unstructured 3S
ensemble, are then oxidized to the native protein by DTTox. Two additional intermediates with
three native disulfide bonds, des-[26–84] and des-[58–110], become observable when oxidative
folding is carried out at lower temperatures (15°C) (Welker et al., 1999). However, these two
intermediates do not oxidize to the native protein at a significant rate; instead, they reshuffle
back to the unstructured 3S ensemble before proceeding along the major pathways, ultimately to
the native protein (Welker et al., 2001). Formation of the native-like structure in des- [65–72]
and des-[40–95] protects their disulfides from reshuffling back to the 3S ensemble, thereby
enabling them to proceed to the native protein in the presence of DTTox (Narayan et al., 2000).
It is, therefore, of interest to examine the conditions that stabilize native-like structure and
protect the already-formed disulfides in folding intermediates, thus enabling them to proceed to
the native protein. [46][47][48] One stabilizing additive is Dipotassium phosphate (K2HPO4).
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Salts, such as K2HPO4, can alter the stability and folding of proteins by three different
processes: by specific binding to the active site, by nonspecific electrostatic interactions, and by
influencing hydrophobic interactions. Anions, such as phosphate, are known to stabilize proteins
(Hermans and Scheraga, 1961; Ginsburg and Carroll, 1965; von Hippel and Wong, 1965; Collins
and Washabaugh, 1985; Ahmad and Bigelow, 1986; Baldwin, 1996) and peptides (Jelesarov et
al., 1998) and to increase the folding rate of denatured proteins (Schaffer et al., 1975; Prajapati et
al., 1998; Low et al., 2000). An earlier report from our laboratory suggests that phosphate may
catalyze the rearrangement of unstructured three-disulfide intermediates to form des-[65–72] and
des- [40–95] (Low et al., 2000). It was also shown (Low et al., 2000) that des-[26–84] and des[58–110], which accumulate at low temperature (Welker et al., 1999), can be observed at 25ºC if
phosphate ions are present. Among the various observed pathways for the oxidative folding of
RNase A, the dominant one (to the extent of about 80%) involves the early formation of the [6572] disulfide bond to a considerable extent in the 1S ensemble, and the subsequent formation of
des [40-95] (a three-disulfide native-like intermediate) by thiol-disulfide reshuffling reactions of
the 3S ensemble in the rate-determining step. A minor, albeit parallel pathway (to the extent of
about 20%) involves the formation of des [65-72] (another three-disulfide native-like
intermediate) in the rate-determining step by similar thiol-disulfide reshuffling reactions of the
3S ensemble. Both des 40-95] and des [65-72] are then oxidized to the native protein.
[19][20][21]
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Chapter 2
Catalysis of the Oxidative Folding of Bovine Pancreatic Ribonuclease A by
Protein Disulfide Isomerase (PDI)
PDI accelerates the folding rate of RNaseA by inducing two novel ways, by showing its
chaperon activity and by disulfide isomerization.

Chaperon activity of PDI
The mechanism by which a protein molecule folds into the native conformation still remains an
unsolved problem in structural biology. Understanding the folding process will not only
elucidate the fundamental relationship between an amino acid sequence and the threedimensional structure of a protein, but will also provide invaluable information to a variety of
related fields, such as the rational design of novel protein molecules and the understanding of the
pathological states associated with protein misfolding (Dobson & Ellis, 1998). Protein folding in
vitro is generally a spontaneous process leading to a native three-dimensional structure
depending on the amino acid sequence of the protein (Anfinsen, 1973). [22][23] In many cases,
however, folding does not proceed efficiently because of intermolecular aggregation and slow
folding reactions such as disulfide formation or proline isomerization. The folding process can be
particularly slow in the case of cysteine-containing proteins that require the formation of
disulfide bonds (Huppa & Ploegh, 1998). [50][51] Disulfide formation in vivo is catalyzed by
specialized enzymes belonging to a thioredoxin super family, such as PDI (protein disulfide
isomerase) in eukaryotes and Dsb (disulfide bond) proteins in prokaryotes. PDI is a 55 kDa
protein found in the endoplasmic reticulum (ER) where it catalyzes disulfide bond formation and
rearrangement during the maturation of most secretary and membrane bound proteins (Freedman
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et al., 1994; Gilbert, 1998). PDI is not a particularly effective enzyme, consistent with its
abundance in the ER, and high concentrations are often required to observe catalysis of protein
folding both in vivo and in vitro (Lyles & Gilbert, 1991). Despite the information available for
the general effects on the oxidation and rearrangement of the folding of disulfide-containing
proteins, detailed knowledge about the effect of PDI on the mechanism of protein folding still
remains to be elucidated. Depending on the concentrations of foldase and denatured substrate
and the order in which they are added to initiate folding, PDI can exhibit chaperon activity.
When it is present at high concentrations relative to unfolded protein substrate, PDI functions as
a chaperon making folding more productive by increasing the folding rate and by inhibiting
aggregation both for denatured proteins with no sulfide bonds and the proteins containing
disulfide bonds.[24][52][53]

PDI catalyzed disulfide isomerization
Non-covalent interactions within the protein that is undergoing folding specify which disulfides
will form most effectively. When disulfide formation occurs early in folding, before the correct
non-covalent structure is developed, cysteine pairing is most likely to be incorrect. Thus protein
folding is error-prone. For some proteins like BPTI, the specification of cysteine connectivity
occurs early in folding and is directed by the formation of native like structure that are
interconverted by intramolecular disulfide rearrangements (Goldenberg,1992). [54] In other
cases such as RNaseA (Creighton, 1979; Konishi et al., 1982) or hirudin (Chatrenet and Chang,
1992), disulfides are formed randomly in early folding intermediates. [25] Thus, protein folding
is a process of trial and error. As a catalyst, PDI must deal with different mechanisms for
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directing disulfide formation. The cysteine near the N-terminal of each active site (CGHC)
housed in two, internally homologous thioredoxin-like domain, is essentially for all catalytic
activity, both oxidation and isomerization (Laboissiere et al., 1995; LaMantia and Lennarz, 1993;
Walker et al., 1996). Mutations of the active site cysteine closer to the carboxyl terminus
(CGHC) selectively destroy the ability of PDI to catalyze disulfide formation. However, these
mutants still remain a low but measurable amount of isomerase activity in the presence of
glutathione redox buffer (Laboissiere et al., 1995; Walker et al., 1996). [26][27][28]

Formally, the rearrangements of substrate disulfide do not require the net oxidation or reduction
of PDI or the substrate, but a substrate disulfide must be broken to initiate rearrangement. The
first step of isomerization involves a reduced PDI active site attacking a substrate disulfide. After
the initial reaction, two different mechanisms could result in substrate isomerization depending
on the covalent PDI-substrate intermediate partitions. In the first mechanism, an intramolecular
rearrangement in the substrate may occur when the sulfhydryl of the substrate cysteine generated
by PDI reacts intramolecularly with another substrate disulfide. In this mechanism, PDI
facilitates reactions between the thiols and disulfides of the substrates while the substrate is
covalently bound to PDI. The intramolecular rearrangement concludes when a substrate disulfide
cysteine displaces PDI from the covalent complex, forming another in the substrate and
regenerating reduced PDI for another round of catalysis. [56][57] In the second mechanism, PDI
can resolve the covalent intermediate by reducing cycles of substrate reduction and reoxidation
in a different configuration lead to isomerization, eventually leading to the native structure.
Several lines of evidences suggest that the reduction oxidation pathway contributes to the
isomerization of scrambled sRNaseA by PDI; 1) Isomerization is inhibited at high concentration
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of RNaseA; such inhibition can be relieved by addition of oxidized PDI (Schwaller et al., 2003).
For an intramolecular isomerization, there is no role for oxidized PDI. 2) In the absence of redox
buffer, PDI mutants with only a nucleophilic cysteine (CGHS) have no isomerase activity. The
second active site cysteine is essential for isomerization of sRNaseA (Walker et al., 1996), but it
plays no role in an intramolecular mechanism. 3) Reduced PDI rapidly oxidized when mixed
with sRNaseA before any isomerization occurs suggesting that substrate is released before native
RNaseA forms (Schwaller et al., 2003). 4) Low levels of covalent PDI-substrate intermediates
are detected with wild type PDI, but such intermediates build up with CGHS mutants (Walker
and Gilbert, 1997) indicating that second cysteine limits their accumulation. While
isomerizationof sRNaseA by PDI may proceed through the reduction-oxidation pathway, other
substrate may utilize the intramolecular pathway and even sRNaseA may utilize it with low
frequency. [93][94][95]
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Fig.5. PDI dependant thiol oxidation and isomerization activity.

We already know that wild type PDI has tremendous potentiality to accelerate the oxidative
folding of RNaseA or formation of similar protein disulfide bond formation by its catalytic and
chaperone activity. In our lab, we are trying to see the potency of each domain of wild type PDI
if they are showing same functional activity or more or less activity. Our primary aim is to use
small molecule to catalyze disulfide bond formation. The small is the molecule the better is in
the body. If we find any of the PDI domains are showing same potency as wild type PDI or
showing better activity than the wild type PDI we can use that very small domain instead of a
whole big molecule. We tried with two different domains, PDI ab and PDI a’b’ to see their
potency in disulfide bond formation comparing to wild type PDI. PDI ab and PDI a’b’ both are
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thioredoxin like domains of wild type PDI, so, we are expecting acceleration in disulfide bond
formation. But, to know the actual potency of these two domains we have to perform the
oxidative protein folding experiment with the substrate protein RNaseA which has four disulfide
bonds (8 free thiol groups). [29][30][59][60]

Materials and Methods
Materials: RNase A was purchased from Sigma and was purified properly (Rothwarf D.M.,
and Scheraga H.A., 1998 et al.,)
Wild type PDI, PDI ab and PDI a’b’ plasmids were brought from Sweden and were expressed in
E.Coli (BL21 strain).

Methods: PDI ab and PDI a’b’ expression. 100 µl aliquot BL21(DE3) competent cell was
taken out from -80ºC, and was Thawed on ice bucket for 10 min. PDI plasmid was taken out
from -20ºC and was thawed too. 1 µl of the plasmid was added into 100 µl BL21 cell tube, and
was kept on Ice for 30 min.
# the amount of plasmid may vary depending on the concentration of plasmid and the
competitiveness of BL21.
Heat shock was given for 60 sec. at 42ºC. (Isotemp should be pre-equilibrated).Then the cell was
Put it back on ice for 2 min. (meanwhile, prepare 1 ml LB in a 15 ml Falcon tube). 100 µl
transformed BL21was transferred to the 1 ml LB, and kept in 37ºC incubator with shaking at 150
rpm for 45 min. (meanwhile, LB-Amp plate was taken out from 4ºC and equilibrated to room
temp.) 100 µl of the LB (45 min incubated 1 ml LB) was spread onto the LB-Amp plate. The
LB/AMP plate was Incubated at 37ºC for 13 hrs. (It may vary ± 2hrs).After overnight incubation,
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next day, a single colony was picked up into 50ml LB and add 0.1 ml of Ampicillin(Stock
concentration is 50 mg/ml and final concentration in 50 ml LB is 0.1 mg/ml) in 250 ml
Erlenmeyer flask, and incubate at 37ºC with shaking at 150 rpm until OD600 reaches 0.5. Starter
culture O.D should not be allowed to exceed 0.5.
•

It will take ≈ 4hr. Check OD600 after 3 hr.

•

OD doubles, generally in 20 min.

25 ml of the starter culture was incubated into 1 L LB and add 2 ml of ampicillin stock was
added, and Incubated until OD600 reaches 0.55-0.6.
•

It will take ≈ 3-4 hrs.

When the OD600 reaches 0.55-0.6, 1 ml of IPTG (0.5 M) was added, and it was shaken 4 more
hours. Then, ells were harvested by centrifuging at 5,000 rpm for 10 min at 4 OC. Supernatant
was discarded and resuspended with lysis buffer (No more than 20 ml).
Lysis buffer: 300 mM NaCl, 50 mM PO4, and 10 mM Imidazole, pH 7.5
Resuspended cells were placed in 50 ml Falcon Tube and were sonicated. The condition must be
set up with each machine.
# Four 30-sec-sonications and 1 min cooling between each sonication.
# Sonication must be done in Ice-Bucket.
Then the cells were centrifuged at 11,000 rpm for 40 min at 4OC. Supernatant was taken and the
pellet was discarded. The supernatant was poured onto Ni-NTA resin in column and purified.
Then the protein was run on SDS gel and Experian gel to for confirmation by molecular weight
with proper protein ladder.
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1

2

3

L

↓55KD

← 50KD

← 40KD
← 30KD

← 15KD

Fig.6. Wild type PDI in SDS gel. L- ladder, 1-First wash (300 mM NaCl, 50 mM PO4, and 50
mM Imidazole, pH 7.5), 2- Second wash (300 mM NaCl, 50 mM PO4, and 100 mM Imidazole,
pH 7.5), and 3- Third wash (300 mM NaCl, 50 mM PO4, and 300 mM Imidazole, pH 7.5). PDI
protein came out as 55 KD molecular weight.

Fig.7. Experion gel picture for wild type PDI shows molecular weight of wild type PDI is 55KD
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Fig.8. Experion gel pic shows PDIab and PDIa’b’ with their exact molecular weight

↓13.4KD

←20KD

Fig.9. SDS gel pic which shows
RNaseA with its 13.4KD
molecular weight

←10KD

←5KD

Preparation of Fully Reduced RNase A. Purified native RNase A was reduced by
incubating the protein in a buffer containing 100 mM DTTred and 6 M GnHCl (100 mM TrisHCl, 1 mM EDTA, pH 8.3, 25 °C). After incubation for 3h, the pH of the solution was lowered
to 3 by addition of glacial acetic acid. The reduced protein was desalted (and DTTred was
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removed) on a reversed-phase HPLC column (C-18) and lyophilized to remove the organic
solvent and water. Lyophilized reduced protein was dissolved in a dilute acetic acid solution (1µl
of glacial acetic acid with 100 ml of mili Q, pH 3.7) to obtain a stock solution (5.0 mg/mL) and
was stored at -20 °C. [31]

Oxidative Folding of RNase A. Oxidative folding of RNaseA was carried out at 25 ºC in
four different test tubes with different reagents by incubating 0.5 mg/mL (33 µM) reduced
protein in a oxidizing buffer of 100 mM DTTox (pH 8.3, 100 mM Tris-HCl, 1 mM EDTA). No
DTTred was present in the original oxidation buffer, but DTTred accumulated during the
oxidation reaction. Aliquots of 200 µL were withdrawn at different times after the initiation of
oxidative folding, and any free thiols were blocked by an excess amount of AEMTS (final
concentration of 50 mM, pH 8.3, 100 mM Tris-HCl and 1 mM EDTA). Five minutes after the
addition of the AEMTS, the pH of the solution was lowered to 3 by addition of 20 µL of glacial
acetic acid. All samples were desalted on a Hi-Trap G25 column by exchange against a 0.2%
acetic acid solution before analysis using cation-exchange HPLC. Prior to the addition of
AEMTS which blocks any free thiols, some samples were subjected to a reduction pulse (5 mM
DTTred at pH 8.3 for 2 min) which results in the reduction of all unstructured species to the fully
reduced protein (R), a procedure that has been used successfully to identify and isolate structured
species in the oxidative folding of RNaseA. [31][32]
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Results and discussions
Results
First test tube contains RNaseA (Final conc. 30µM) and oxidizing buffer. In second test tube
RNaseA (Final conc 30µM) added with oxidizing buffer and wild type PDI (Final conc. 6µM).In
the next one we added RNaseA (Final conc.30µM), oxidizing buffer, PDI ab (Final conc. 6µM),
and in last test tube we added RNaseA (Final conc. 30µM), oxidizing buffer, PDI a’b’ (Final
conc. 6µM. No DTTred was present in the original oxidation buffer, but DTTred accumulated
during the oxidation reaction. Aliquots of 200 µL were withdrawn at different times after the
initiation of oxidative folding, and any free thiols were blocked by an excess amount of AEMTS
(final concentration of 50 mM, pH 8.3, 100 mM Tris-HCl and 1 mM EDTA). Five minutes after
the addition of the AEMTS, the pH of the solution was lowered to 3 by addition of 20 µL of
glacial acetic acid.
The table (1) below is the typical calculation formula for calculation of fraction of reduced and
native protein. Results from these experiments showed that the rate of formation of the native
protein (N) which is indicated by Ln (1-n) where (1 – n) is the fractional concentration of nonnative RNaseA. Ti, T2 and so on are the different time points where 200µl of aliquots were
withdrawn. Times are calculated in minutes and each aliquot was withdrawn at different time
intervals. All four experiments were started with fully reduced (R) RNaseA, as the time increases
RNaseA gradually become folded and as a result native (N) fraction of RNaseA increases with
time. In HPLC chromatogram two peaks are visible, one for reduced protein and another for
native protein. As the protein enrich by native fraction the hydrophobic part goes in the core of
the protein, unlikely, in the reduced protein hydrophobic portion will be exposed outside of the
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amino acid chain, which leads the native peak to come before the reduced one because our
HPLC column has long hydrocarbon (C18) chain which is very strong hydrophobic. As the
reduced protein has exposed hydrophobic part it binds strongly with the column comparing to the
native protein and stick to the column for a longer time than the native protein and as a
consequence the reduced protein comes after the native one. With the help of area calculator, we
can calculate the area of reduced (R) RNaseA and the area of native (N) RNaseA. Once we get
all the Reduced and Native area at different time interval we can calculate the formation of
native fraction of RNaseA by the following calculation.
Table1
Time
Point

Time(mins)

Native(N)

reduced®

N+R

N/N+R

(1-n)

Ln(1-n)

T0

M0

N1

R1

X1

Y1

Z1

F1

T1

M1

N2

R2

X2

Y2

Z2

F2

T2

M2

N3

R3

X3

Y3

Z3

F3

T3

M3

N4

R4

X4

Y4

Z4

F4

T4

M4

N5

R5

X5

Y5

Z5

F5

T5

M5

N6

R6

X6

Y6

Z6

F6

T6

M6

N7

R7

X7

Y7

Z7

F7

T7

M7

N8

R8

X8

Y8

Z8

F8

T8

M8

N9

R9

X9

Y9

Z9

F9

T9

M9

N10

R10

X10

Y10

Z10

F10

Experiment1: first test tube contains RNaseA (Final conc. 30µM) and oxidizing buffer.
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Table (2) below comprises all the data we have from HPLC.
Table2.
Time
Time
Native
Reduced
N+R
N/N+R
point
(Mins)
(N)
(R)
(n)
T1
40
1.7
105.3
107
0.0159
T2
60
29.23
382.44
411.67
0.071
T3
80
62.24
722.4
784.64
0.0793
T4
100
81
908.47
989.47
0.082
T5
120
81.9
858
939.9
0.0871
T6
140
104.8
881
985.8
0.1063
T7
160
104.1
781
885.1
0.1176
T8
180
110.2
781.34
891.6
0.1236
T9
200
76.6
458.9
535.5
0.143
After we calculated native fraction (ln (1-n)) at different time interval

(1-n)
0.9841
0.929
0.9207
0.918
0.913
0.8937
0.8824
0.8764
0.857
we plotted

Ln(1-n)
-0.016
-0.0736
-0.0826
-0.0856
-0.091
-0.1124
-0.1251
-0.1319
-0.1543
the data in

excel and we get a figure like below.

From table 2 we get the following figure
RNaseA+Oxidizing buffer

Fig.10. gives us different native fractions at different time points when oxidative folding of
RNaseA is done with only oxidizing buffer. We added a trend line through the curve we get from
different data point. It gives us a straight line equation (Y= mX + C), where m is the slope of the
straight line.
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Experiment 2: second test tube contains RNaseA (Final conc. 30µM) added with oxidizing
buffer and PDI (Final conc. 6µM). Table (3) below comprises all the data we have from HPLC.

Table 3
Time
Point
T2
T3
T4
T5
T6
T7
T8
T9
T10
T11

Time
(Mins)
40
60
80
100
120
140
160
180
200
220

Native
(N)
29.7
40.75
65.3
73.6
87.1
111.5
127.73
160.4
163.3
149.5

Reduced
(R)
339
340
292.5
287.84
286.44
256.3
287.56
309.4
304.67
286.1

N+R
368.7
380.75
357.8
361.44
373.5
367.8
415.29
469.8
467.97
335.6

From table 3 we get the following figure
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N/N+R
(n)
0.0855
0.107
0.1825
0.2036
0.2331
0.3031
0.3075
0.3414
0.3491
0.4204

(1-n)

Ln(1-n)

0.9145
0.893
0.8175
0.7964
0.7669
0.6969
0.6925
0.6586
0.6509
0.5796

-0.0894
-0.1132
-0.2015
-0.2277
-0.2714
-0.3611
-0.3674
-0.4176
-0.4294
-0.5454

RNaseA+Oxidizing buffer + WT PDI

Fig.11. gives us different native fractions at different time points when oxidative folding of
RNaseA is done with oxidizing buffer and wild type PDI (Final conc. 6µM).We added a trend
line through the curve we get from different data point. It gives us a straight line equation (Y=
mX + C), where m is the slope of the straight line.

Experiment 3: Third test tube contains RNaseA (Final conc. 30µM) added with oxidizing
buffer and PDIab (Final conc. 6µM). Table (4) below comprises all the data we have from
HPLC.
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Table 4
Time
point
T0
T1
T2
T3
T4
T5
T6
T7
T8
T9

Time
(Mins)
5
30
60
150
180
240
300
330
360
420

Native
(N)
58
52.2
43.7
96.1
128.3
122.2
193.7
157.5
133.7
267.5

Reduced
(R)
617.1
541
443.1
475.1
519.3
479.8
587
428.5
326
554.6

N+R
675.1
593.2
486.8
571.2
647.6
602
780.7
586
459.7
822.1

N/N+R
(n)
0.086
0.088
0.09
0.168
0.198
0.203
0.248
0.269
0.291
0.325

(1-n)

Ln(1-n)

0.914
0.912
0.91
0.832
0.802
0.797
0.752
0.731
0.709
0.675

-0.09
-0.092
-0.094
-0.184
-0.221
-0.227
-0.285
-0.313
-0.344
-0.393

From table 4 we get following figure
PDIab+RNaseA+Oxidizing buffer

Fig.12. gives us different native fractions at different time points when oxidative folding of
RNaseA is done with oxidizing buffer and PDI ab (Final conc. 6µM).We added a trend line
through the curve we get from different data point. It gives us a straight line equation (Y= mX +
C), where m is the slope of the straight line.
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Experiment 4: Last test tube contains RNaseA (Final conc. 30µM) added with oxidizing
buffer and PDI a’b’ (Final conc. 6µM). Table (5) below comprises all the data we have from
HPLC.

Table5
Time
point
T0
T1
T2
T3
T4
T5
T6
T7
T8
T9

Time
(Mins)
5
30
60
150
180
240
300
330
360
420

Native
(N)
55.3
59.6
79
107.7
155.8
208.2
180
229.2
214.2
220.4

Reduced
(R)
565.5
600.3
558.3
665.2
448.6
584.6
386.4
473.2
408.3
358.6

N+R
620.8
659.9
637.3
772.9
604.4
792.8
566.4
702.4
622.5
579

From table 5 we get the following figure
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N/N+R
(n)
0.089
0.09
0.124
0.139
0.258
0.263
0.318
0.326
0.344
0.381

(1-n)

Ln(1-n)

0.911
0.91
0.876
0.861
0.742
0.737
0.682
0.674
0.656
0.619

-0.093
-0.094
-0.132
-0.15
-0.298
-0.305
-0.383
-0.395
-0.422
-0.48

PDI a’b’+ RNaseA+Oxidizing buffer

Fig.13. gives us different native fractions at different time points when oxidative folding of
RNaseA is done with oxidizing buffer and PDI a’b’ (Final conc. 6µM).We added a trend line
through the curve we get from different data point. It gives us a straight line equation (Y= mX +
C), where m is the slope of the straight line.
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Blue: RNaseA+oxidizing
buffer

Green: RNaseA+oxidizing
buffer+PDIab

Violet: RNaseA+oxidizing
buffer+PDIa’b’

Red: RNaseA+oxidizing
buffer+WTPDI

Fig.14. Folding rate from experiment 1, 2, 3, 4 together.

Table.6. Rate constant from experiment 1, 2, 3, and 4 together.
Reaction
For RNaseA

Rate constant (Mmin)-1

Ratio

Uncatalyzed

6.0X10^-4

-

Catalyzed with WT PDI

23.0X10^-4

3.83

Catalyzed with PDI ab

8.0X10^-4

1.33

Catalyzed with PDI a’b’

12.0X10^-4

2.00
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Discussions:
From fig 10, 11, 12, 13 we get protein folding curves which are been formed by different native
fractions in respect to different time. Every curve has a straight line equation with a specific
slope (m). This “m” indicates rate of protein folding. If we consider experiment 1(RNaseA and
Oxidizing buffer only) and experiment 2 (Wild type PDI is added to RNaseA and Oxidizing
buffer mixture) we can see wild type PDI is accelerating oxidative folding of RNaseA to a
significant amount. When we performed oxidative folding of RNaseA with oxidizing buffer only
we get slope “m” of 0.0006, after adding wild type PDI in experiment 2 slope “m” is 0.0023.
First experiment was carried out for 200 minutes where second one was for 220 minutes. When
we added wild type PDI to RNaseA folding rate is much higher and gave high native fraction,
that means, wild type PDI is typically active with its catalytic and isomerization. Wild type PDI
is increasing the folding rate around 4 folds.

In our third experiment, we added PDI ab instead of wild type PDI and experiment was carried
out for 420 minutes, here, RNaseA folding rate is 0.0008 and which is little faster than first
experiment which was done without any chaperon protein. Again, this rate is very less than
second experiment which is done with wild type PDI (slope was 0.0023). So, PDI ab domain
makes the folding rate faster to some extent but it has very less activity than wild type PDI. PDI
ab domain is increasing the folding rate around 1.33 folds.

In our fourth experiment, we added PDI a’b’ to RNaseA and oxidizing buffer mixture and the
experiment was carried out for 420 minutes as well. Here, we get a slope of 0.001 which is little
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higher than PDI ab, fraction of native RNaseA is little higher than fraction of native produced in
experiment with PDI ab. But, the rate of folding is much less than wild type PDI, so as native
protein fraction is also very less than it produced in case of wild type PDI.PDi a’b’ is increasing
the folding rate around 2 folds.

From above results, we see that PDI is losing its typical activity when it is used as different
single domain, like PDIab and PDIa’b’ and subsequently protein folding rate is also decreasing
when PDI is used as different domain instead of multidomain PDI. But, still single domain of
PDI (PDIab and PDIa’b’) has some activity which can accelerate the folding rate to a certain
amount and production of native protein is relatively higher than it’s being done without single
or multidomain PDI.

PDI consists of four tandem domains with thioredoxin structures, two with redox active sites (a
and a’), and two with no redox activity (b and b’). To understand the relationship between
individual domains and their contributions to the high isomerase activity displayed by full length
of PDI, this experiment was done with various domains combinations constructed using a
systemic genetic engineering approach. We isolated each protein in soluble and sufficiently pure
form to characterize their activity. The activity of ab and a’b’ in RNaseA folding is very low. As,
b and b’ has no redox activity the isomerase activity of ab and a’b’ is significantly lower than of
full length PDI. Our data suggest that although, PDI ab and PD Ia’b’ getting lowered in it’s
isomerase activity than full length PDI these two constructs accelerate RNaseA folding rate
greater than RNaseA been folded without any PDI and PDI a’b’ accelerate RNaseA folding little
higher than PDI ab.
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Conclusion
From all above information we can conclude with following collusions:
Ability of different PDI domains to contribute to a significant isomerase activity is a function of
context rather than the property of single domain.

PDIab and PDIa’b’ have much lower isomerase activity than multidomain PDI, so as full length
PDI is required to accelerate thiols containing protein folding for its high isomerase activity.

PDIa’b’ is little more active than PDIab construct as it increases RNaseA folding rate in a little
higher account.

pKa factor might be the reason for this type of result. Normally pKa value of wild type PDI is
around 5.4 and our experiment is done in pH8. While pH is much greater than pKa thiols become
active thiolate. But normal pKa of cysteine is around 8 which is very high. When we do the
experiment with PDI domains the all thiol groups don’t turn in to active thiolate. This might
results less activity of PDI domains in compare to wild type PDI.
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Chapter 3
Targeting Nitrosative Stress Effects on an Er-Resident Oxidoreductase
through Small-Molecule Ethnopharmaceuticals Intervention: Implications for
Age- And Neurodegeneration-Related Disorders
Introduction
Protein quality control is a critical feature of intracellular homeostasis. In particular, unfolded or
misfolded proteins resulting from environmental stresses or free radicals are rapidly degraded via
the ubiquitin-proteasome pathway. Nitric oxide (NO), a free radical gas, has been reported to be
involved in such processes as vasorelaxation and neurotransmission. Conversely, NO also is
implicated in neuronal cell death or neurodegeneration. Recent reports suggest that Snitrosylation of proteins is a significant cause of neural dysfunction leading to neurodegenerative
disorders. Specifically, S-nitrosylation of Parkin eventually leads to the accumulation of
unfolded proteins and subsequent neuronal death. The focus of this review is the identity of the
target of NO. [61][62] Nitrosative stress prevents normal functioning of the endoplasmic
reticulum (ER) via S-nitrosylation of protein-disulfide isomerase (PDI), which is located in the
ER lumen. This may contribute to the accumulation of misfolded proteins, as well as sustained
activation of the unfolded protein response (UPR) pathway. These phenomena may be linked to
the development of sporadic neurodegenerative diseases. Over activation of N-methyl-Daspartate (NMDA)-type glutamate receptors accounts, at least in part, for excitotoxicity neuronal
damage, potentially contributing to a wide range of acute and chronic neurologic disorders.
Recent studies have suggested that generation of excessive nitric oxide (NO) and reactive
oxygen species (ROS) can mediate excitotoxicity, in part by triggering protein misfolding. SNitrosylation, which is a covalent reaction of a NO group with a cysteine thiol, represents one
such mechanism that can contribute to NO-induced neurotoxicity. The ubiquitin-proteasome
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system (UPS), in conjunction with molecular chaperones, can prevent accumulation of
aberrantly-folded proteins. Chaperon PDI can provide neuroprotection from misfolded proteins
or endoplasmic reticulum stress through its molecular chaperone and thiol-disulfide
oxidoreductase activities. [63][64] Here, the authors present recent evidence suggesting that NO
contributes to degenerative conditions by S-nitrosylating PDI (forming SNO-PDI) and the
ubiquitin protein ligase, parkin (forming SNO-parkin). Moreover, it is demonstrated for the first
time that inhibition of excessive NMDA receptor activity by memantine, via a mechanism of
uncompetitive open-channel block with a relatively rapid off-rate, can ameliorate excessive
production of NO, protein misfolding, and neurodegeneration. Misfolded proteins, and the
associated endoplasmic reticulum (ER) stress, are emerging as hallmarks of age- and
neurodegeneration-related disorders such as Huntington’s disease (HD), Alzheimer’s disease
(AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis. Recent and compelling
evidence has linked nitrosative stress and the ER-resident oxidoreductase, protein disulfide
isomerase (PDI), to the pathogenesis of PD and AD. Overexpression of PDI has been found to
reduce the formation of polyubiquitinated proteins, making the oxidoreductase an important
target for therapeutic intervention in PD, AD and other age- and neurodegeneration-related
disorders. We demonstrate the NO-scavenging ability of the biphenolic natural products
curcumin and masoprocol and the concomitant prevention of S-nitrosylation of PDI by a model
NO-donor. Furthermore, both ethnopharmaceuticals accelerate protein fold acquisition in their
neat and nitrated forms, making them attractive candidates for prevention of age- and
neurodegeneration-related diseases. [65][66][67][69]
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Protein misfolding in neurodegenerative diseases
A shared histological feature of many neurodegenerative diseases is the accumulation of
misfolded proteins that adversely affect neuronal connectivity and plasticity, and trigger cell
death signaling pathways. For example, degenerating brain contains aberrant accumulations of
misfolded, aggregated proteins, such as a-synuclein and synphilin-1 in PD, and amyloid-b (Ab)
and tau in AD. The inclusions observed in PD are called Lewy bodies and are mostly found in
the cytoplasm. AD brains show intracellular neurofibrillary tangles, which contain tau, and
extracellular plaques, which containAb. Other diseases with inclusions include Huntington_s
(polyQ), ALS, and prion disease. The above-mentioned aggregates consist of oligomeric
complexes of non-native secondary structures, and demonstrate poor solubility in aqueous or
detergent solvent. [70] It has been suggested that either genetic mutations or an increase in
nitrosative/ oxidative stress can facilitate protein aggregation. In general, protein aggregates do
not accumulate in unstressed, healthy neurons due in part to the existence of cellular quality
control machineries. For example, molecular chaperones are believed to provide a defense
mechanism against the toxicity of misfolded proteins because chaperones can prevent
inappropriate interactions within and between polypeptides, and can promote refolding of
proteins that have been misfolded because of cell stress. In addition to the quality control of
proteins provided by molecular chaperones, the ubiquitin-proteasome system (UPS) is involved
in the clearance of abnormal or aberrant proteins. When chaperones cannot repair misfolded
proteins, they may be tagged via addition of polyubiquitin chains for degradation by the
proteasome. [71] In neurodegenerative conditions, intra- or extracellular protein aggregates are
thought to accumulate in the brain as a result of a decrease in molecular chaperone or proteasome
activities. In fact, several mutations that disturb the activity of molecular chaperones or UPS-
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associated enzymes can cause neurodegeneration. Historically, lesions that contain aggregated
proteins were considered to be pathogenic. Recently, several lines of evidence have suggested
that aggregates are formed through a complex multi-step process by which misfolded proteins
assemble into inclusion bodies; currently, soluble oligomers of these aberrant proteins are
thought to be the most toxic forms via interference with normal cell activities, while frank
aggregates may be an attempt by the cell to wall off potentially toxic material. [72][73]

Protein S-nitrosylation and neuronal cell death
Early investigations indicated that the NO group mediates cellular signaling pathways, which
regulate broad aspects of brain function, including synaptic plasticity, normal development, and
neuronal cell death. In general, NO exerts physiological and some pathophysiological effects via
stimulation of guanylate cyclase to form cyclic guanosine-3_, 5_-monophosphate (cGMP) or
through S-nitros(yl)ation of regulatory protein thiol groups. SNitrosylation is the covalent
addition of anNOgroup to a critical cysteine thiol/sulfhydryl (RSH or, more properly, thiolate
anion, RS–) to forman S-nitrosothiol derivative (R-SNO). Such modification modulates the
function of a broad spectrumof mammalian, plant, and microbial proteins. In general, a
consensus motif of amino acids comprised of nucleophilic residues (generally an acid and a base)
surrounds a critical cysteine, which increases the cysteine sulfhydryl_s susceptibility to Snitrosylation.Our group first identified the physiological relevance of S-nitrosylation by showing
that NO and related RNS exert paradoxical effects via redox-based mechanisms – NO is
neuroprotective via S-nitrosylation of NMDA receptors (as well as other subsequently
discovered targets, including caspases), and yet can also be neurodestructive by formation of
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peroxynitrite (or, as later discovered, reaction with additional molecules such as MMP-9 and
GAPDH). Over the past decade, accumulating evidence has suggested that S-nitrosylation can
regulate the biological activity of a great variety of proteins, in some ways akin to
phosphorylation. Chemically, NO is often a good “leaving group,” facilitating further oxidation
of critical thiol to disulfide bonds among neighboring (vicinal) cysteine residues or, via reaction
withROS, to sulfenic (-SOH), sulfinic (-SO2H) or sulfonic (-SO3H) acid derivatization of the
protein. Alternatively, S-nitrosylation may possibly produce a nitroxyl disulfide, in which the
NO group is shared by close cysteine thiols. Analyses of mice deficient in either nNOS or iNOS
confirmed that NO is an important mediator of cell injury and death after excitotoxic stimulation;
NO generated from nNOS or iNOS is detrimental to neuronal survival. In addition, inhibition of
NOS activity ameliorates the progression of disease pathology in animal models of PD, AD, and
ALS, suggesting that excess generation of NO plays a pivotal role in the pathogenesis of several
neurodegenerative diseases. Although the involvement of NO in neurodegeneration has been
widely accepted, the chemical relationship between nitrosative stress and accumulation of
misfolded proteins has remained obscure. Recent findings, however, have shed light on
molecular events underlying this relationship. Specifically, we recently mounted physiological
and chemical evidence that S-nitrosylation modulates the (i) ubiquitin E3 ligase activity of
parkin, and (ii) chaperone and isomerase activities of PDI, contributing to protein misfolding and
neurotoxicity in models of neurodegenerative disorders. Additionally, Cohen et al. Recently
demonstrated that insulin/insulin-like growth factor-I (IGFI) signaling, which influences
longevity and lifespan in many species in part via down-regulation of ROS/ RNS generation, can
affect aggregation of toxic proteins such as Ab. This finding potentially provides an additional
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link between ROS/RNS production during the normal aging process and protein aggregation in
neurodegenerative conditions. [74][75][76]

Unfolded protein response (UPR) and PDI
The ER normally participates in protein processing and folding but undergoes a stress response
when immature or misfolded proteins accumulate. ER stress stimulates two critical intracellular
responses. The first represents expression of chaperones that prevent protein aggregation via the
unfolded protein response (UPR), and is implicated in protein refolding, post-translational
assembly of protein complexes, and protein degradation. This response is believed to contribute
to adaptation during altered environmental conditions, promoting maintenance of cellular
homeostasis. At least three ER transmembrane sensor proteins are involved in the UPR:
pancreatic ER kinase (PKR)-like ER kinase (PERK), activating transcription factor 6 (ATF6),
and inositol-requiring enzyme 1 (IRE1). The activation of all three proximal sensors results in
the attenuation of protein synthesis via eukaryotic initiation factor-2 (eIF2) kinase and increased
protein folding capacity of the ER. The second ER stress response, termed ER-associated
degradation (ERAD), specifically recognizes terminally misfolded proteins for retrotranslocation across the ER membrane to the cytosol, where they can be degraded by the UPS.
Additionally, although severe ER stress can induce apoptosis, the ER withstands relatively mild
insults via expression of Cell. These proteins behave as molecular chaperones that assist in the
maturation, transport, and folding of secretary proteins. [77][78] During protein folding in the
ER, PDI catalyzes thiol/ disulfide exchange, thus facilitating disulfide bond formation,
rearrangement reactions, and structural stability. PDI has four domains that are homologous to
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thioredoxin (TRX) (termed a, b, b_, and a_). Two of the four TRX-like domains (a and a_)
contain a characteristic redox-active CXXC motif, and these two-thiol/disulfide centers function
as independent active sites. The recently determined structure of yeast PDI revealed that the four
TRX-like domains form a twisted “U” shape with the two active sites facing each other on
opposite sides of the “U”. Hydrophobic residues line the inside surface of the “U,” facilitating
interactions between PDI and misfolded proteins. In many neurodegenerative disorders and
cerebral ischemia, the accumulation of immature and denatured proteins results in ER
dysfunction, but up-regulation of PDI represent an adaptive response promoting protein refolding
and may offer neuronal cell protection. In a recent study, we reported that the S-nitrosylation of
PDI (to form SNO-PDI) disrupts its neuroprotective role. [79][80]

S-Nitrosylation of PDI mediates protein misfolding and neurotoxicity in cell
models of PD or AD
In contrast to the highly reducing environment of the cytosol and mitochondria, the ER manifests
a relatively positive redox potential (e.g., the ratio of reduced: oxidized glutathione is
approximately 3:1). [81]
This redox environment can contribute to the stability of protein S-nitrosylation or oxidation.
Recently, we reported that excessive NO can lead to SNitrosylation of the active site thiol groups
of PDI, and this reaction inhibits both its isomerase and chaperone activities. Mitochondrial
complex I insult by rotenone can also result in S-nitrosylation of PDI in cell culture models.
Moreover, we found that PDI is Snitrosylated in the brains of virtually all cases examined of
sporadic AD and PD. Additionally, it is possible that vicinal (nearby) cysteine thiols reacting
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with NO can form nitroxyl disulfide [82][83], and such reaction may potentially occur in the
catalytic side of PDI to inhibit enzymatic activity. To determine the consequences of Snitrosylated PDI (SNO-PDI) formation in neurons, we exposed cultured cerebrocortical neurons
to neurotoxic concentrations of NMDA, thus inducing excessive Ca2+ influx and consequent NO
production from nNOS. Under these conditions, we found that PDI was S-nitrosylated in a NOS
dependent manner. SNO-PDI formation led to the accumulation of polyubiquitinated/misfolded
proteins and activation of the UPR. Moreover, S-nitrosylation abrogated the inhibitory effect of
PDI on aggregation of proteins observed in Lewy body inclusions. [84] S-Nitrosylation of PDI
also prevented its attenuation of neuronal cell death triggered by ER stress, misfolded proteins,
or proteasome inhibition. Further evidence suggested that SNO-PDI may in effect transport NO
to the extracellular space, where it could conceivably exert additional adverse effects. In addition
to PDI, S-nitrosylation is likely to affect critical thiol groups on other chaperones, such as HSP90
in the cytoplasm and possibly GRP in the ER. Normally, HSP90 stabilizes misfolded proteins
and modulates the activity of cell signaling proteins including NOS and calreticulin. [85][86] In
AD brains, levels of HSP90 are increased in both the cytosolic and membranous fractions, where
HSP90 is thought to maintain tau and Ab in a soluble conformation, thereby averting their
aggregation. (Mart_- nez-Ruiz et al).Recently demonstrated that SNitrosylation of HSP90 can
occur in endothelial cells, and this modification abolishes its ATPase activity, which is required
for its function as a molecular chaperone. These studies imply that S-nitrosylation of HSP90 in
neurons of AD brains may contribute to the accumulation of tau and Ab aggregates. The UPS is
apparently impaired in the aging brain. Additionally, inclusion bodies similar to those found in
neurodegenerative disorders can appear in brains of normal aged individuals or those with
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subclinical manifestations of disease. These findings suggest that the activity of the UPS and
molecular chaperones may decline in an age-dependent manner. Given that we have not found
detectable quantities of SNO parkin and SNO-PDI in normal aged brain, we speculate that Snitrosylation of these and similar proteins may represent a key event that contributes to
susceptibility of the aging brain to neurodegenerative conditions. With bacitracin can increase
aggregation of mtSOD1 in neuronal cells. Moreover, PDI co-localized and bound to intracellular
aggregates of mtSOD1. [87][88] Upregulation of the UPR was also observed in mtSOD1 mice.
These findings suggest that ER stress may contribute to the pathophysiology of familial ALS,
and PDI could potentially reduce mtSOD1 aggregation and affect neuronal survival.
Interestingly, Snitrosothiol levels have also been found to be abnormal in the spinal cords of
mtSOD1 transgenic mice. Whether SNO-PDI is involved in SOD1 aggregation and motor
neuron injury in ALS remains to be studied. Finally, transmissible spongiform encephalopathy
(TSE), also known as prion diseases, is transmissible neurodegenerative disorders and includes
Creutzfeldt-Jacob disease, bovine spongiform encephalopathy,

and scrapie. Cerebral

accumulation of misfolded prion protein (PrP) and extensive neuronal apoptosis represent
pathological hallmarks of these prion diseases. Recent reports have suggested that a prolonged
UPR due to PrP misfolding in the ER may contribute to neuronal dysfunction. This ER stress
response is mainly associated with up-regulation of Grp58, an ER chaperone with PDI-like
activity, suggesting that this chaperone may represent a cellular response to prion infection. In
fact, in vitro studies on Grp58, either over expressing (via transfection) or down-regulating (via
RNAi), demonstrated that this ER chaperone protects cells against PrP misfolding and toxicity.
Collectively, these studies raise the possibility that SNO-PDI and S-nitrosylation of other
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chaperone molecules may represent potential therapeutic targets to prevent protein aggregation
in several neurodegenerative diseases. [89]

Fig.15. Diagram shows how PDI is getting nitrosylated and producing ER stress which leads
cell death.

Small molecule like masoprocol and Curcumin can scavenge the nitro group
and protect PDI to be nitrated

Masoprocol
Plants used to treat non-insulin-dependent diabetes mellitus (NIDDM) offer valuable leads for
the development of pharmaceuticals (Luo et al., 1998; Oubre´ et al., 1997). Oral decoctions and
extracts of the creosote bush Larrea tridentata have been used by the Pima Indians in the
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Southwest United States and Mexico for the treatment of diabetes (Winkelman, 1989).
Masoprocol, a phenolic (fig.16) pure compound from the creosote bush, was evaluated in mouse
models of NIDDM for its ability to lower blood glucose concentration.
Masoprocol, also known as Nordihydroguaiaretic (NDGA), is an antineoplastic drug used to treat
skin growths caused by sun exposure. A form of nordihydroguaiaretic acid that is taken by
mouth is being studied in the treatment of prostate cancer. Nordihydroguaiaretic acid is an
antioxidant, and it may block certain enzymes needed for tumor growth. Masoprocol also called
nordihydroguaiaretic acid, NDGA, and actinex. Systematic (IUPAC) name 4-[4-(3,4dihydroxyphenyl)-2,3-dimethyl-butyl]benzene-1,2-diol. [90]

Masoprocol is a naturally occurring lignan from the creosote bush (Larrea tridentata).
Masoprocol has been utilized in traditional healing practices for a wide range of ailments and
was licensed for use as a topical treatment for actinic keratosis (Actinex, Chemex
Pharmaceuticals, Denver, CO). Use of masoprocol for therapeutic purposes is currently limited
due to reports of contact hypersensitivity, nephrotoxicity, hepatotoxicity, and cytotoxicity. It has
been suggested that the toxicity is the result of oxidation to a reactive ortho-quinone species, the
presence of which we recently confirmed via trapping of NDGA ortho-quinones as glutathione
(GSH) adducts. [91]

Fig.16. Structure of masoprocol.
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Curcumin
Turmeric (fig.17, 18) is a spice derived from the rhizomes of Curcuma longa, which is a member
of the ginger family (Zingiberaceae).Rhizomes are horizontal underground stems that send out
shoots as well as roots. The bright yellow color of turmeric comes mainly from polyphenolic
pigments, known as curcuminoids. Curcumin (fig19) is the principal curcuminoid found in
turmeric, and is generally considered its most active constituent. Other curcuminoids found in
turmeric include demethoxycurcumin and bisdemethoxycurcumin. In addition to its use as a
spice and a pigment, turmeric has been used in India for medicinal purposes for centuries. More
recently, evidence that curcumin may have anti-inflammatory and anticancer activities has
renewed scientific interest in its potential to prevent and treat disease. [92]

Fig.17

Fig.18
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Fig.19
Fig.17. and Fig.18. Turmeric powder. Fig.19. Structure of Curcumin.
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Metabolism and Bioavailability
Clinical trials in humans indicate that the systemic bioavailability of orally administered
curcumin is relatively low. Curcumin is readily conjugated in the intestine and liver to form
curcumin glucuronides and curcumin sulfates or reduced to hexahydrocurcumin. Curcumin
metabolites may not have the same biological activity as the parent compound. [108]In one
study, conjugated or reduced metabolites of curcumin were less effective inhibitors of
inflammatory enzyme expression in cultured human colon cells than curcumin itself. In a clinical
trial conducted in Taiwan, serum curcumin concentrations peaked 1-2 hours after an oral dose,
and peak serum concentrations were 0.5, 0.6 and 1.8 micromoles/liter at doses of 4, 6 and 8
g/day, respectively. Curcumin could not be detected in serum at lower doses than 4 g/day. More
recently, a clinical trial conducted in the UK, found that plasma curcumin, curcumin sulfate and
curcumin glucuronide concentrations were in the range of 10 nanomoles/liter (0.01
micromole/liter) one hour after a 3.6 g dose of oral curcumin. Curcumin and its metabolites
could not be detected in plasma at lower doses than 3.6 g/day. Curcumin and its glucuronidated
and sulfated metabolites were also measured in urine at a dose of 3.6 g/day. There is some
evidence that orally administered curcumin accumulates in gastrointestinal tissues. When
colorectal cancer patients took 3.6 g/d of curcumin orally for 7 days prior to surgery, curcumin
was detected in malignant and normal colorectal tissue. In contrast, curcumin was not detected in
the liver tissue of patients with liver metastases of colorectal cancer after the same dose of oral
curcumin, suggesting that oral curcumin administration may not effectively deliver curcumin to
tissues outside the gastrointestinal tract. [93]
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Biological Activities
Antioxidant activity
Anti-inflammatory activity
Glutathione synthesis
Effects on biotransformation enzymes involved in carcinogen metabolism
Induction of cell cycle arrest and apoptosis
Inhibition of tumor invasion and angiogenesis. [94]

Our first hypothesis was that masoprocol and curcumin are the two substances which can
scavenge nitro group by getting ring nitration or aliphatic chain nitration. Our final aim is to
block the nitro group by small molecule to prevent the thiol groups of PDI to be nitrated. When
thiols are nitrated by nitro group PDI loses its catalytic activity and subsequently substrate
proteins are misfolded in the Endoplasmic reticulum and bring ER stress which ultimately leads
inclusion body formation. To retain the catalytic activity of PDI we have to protect the thiol
groups of PDI from getting nitrated by nitro group. In vitro we have used two small molecules,
like masoprocol and curcumin to protect PDI from nitro group. We added Tetra nitro methane
(TNM), a nitro group donor, with these small molecules and by observing the absorbance in
spectrometry it’s been confirmed that these two small molecules are getting nitrated.
We use UV spectrometry to prove that masoprocol is getting nitrated in the presence of nitro
group (NO)
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Fig.20. shows absorbance

280nmm

of masoprocol is 0.9 at
280 nm wave length.

shows
absorbance
of TNM
(nitro group donor) is
0.04 at 353 nm wave
length

Fig.21.
353nm
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Fig.22. shows absorbance
280nm

of masoprocol after

353nm

adding nitro group donor
is at 280 and 353 nm
wavelength and at 353
nm absorbance is 1.2

280nm

353nm

Fig.23
NB: “Series2” indicates the absorbance of masoprocol
“Series3” indicates the absorbance of TNM
“All together” curve indicates the absorbance when masoprocol is added to TNM
In Fig.23 three curves are plotted together, and we can see that TNM has some absorbance at
353 nm wavelength where as masoprocol only has no absorbance at 353 nm wavelength, but
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masoprocol itself has absorbance at 280 nm wave length. Again when TNM is added with
masoprocol we get two absorbance peak at 280 and 353 nm wavelengths and absorbance at 353
nm wavelength increases almost 30 times which clearly shows that masoprocol is getting nitrated
which resulting a huge increase in the absorbance at 353 nm wavelength.
The results from above four figures prove that masoprocol is getting nitrated in the presence of
nitro group (NO).
We used mass spec to prove that curcumin is getting nitrated in the presence of nitro group (NO).
Figure below is the mass spec result of curcumin with nitro group.

Fig.24. Mass spec. data shows phytochemicals are getting nitrated
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Above mass spec data interprets that mass of curcumin is certainly increasing when TNM is
added with curcumin which proves that curcumin is getting nitrated in the presence of nitro
group (NO).

So, now we came to know that curcumin and masoprocol both phenolic compounds are getting
nitrated in the presence of nitro group (NO). For our future research we will use masoprocol only
as a nitro group scavenger.
Now, we added the small molecules to the chaperon protein PDI and have done oxidative protein
folding of RNaseA to see if the small molecule can get nitrated faster than PDI and scavenges
the nitro group to protect thiols group of PDI from getting nitrated. Our substrate protein is
RnaseA which has four di- sulfide bonds (8 free thiols). So, this is one of the most convenient
proteins for oxidative protein folding experiment.

MATERIALS AND METHODS
Materials: RNase A was purchased from Sigma and was purified properly (Rothwarf D.M.,
and Scheraga H.A., 1998 et al.,)
Tetranitromethane (TNM) was purchased from sigma.
Masoprocol was brought from a medicine company at El Paso.
Protein Di-sulfide Isomerase (PDI) plasmid was brought from Sweden and was expressed in
E.Coli (BL21 strain).
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Methods:
PDI expression. 100 µl aliquot BL21(DE3) competent cell was taken out from -80ºC, and was
Thawed on ice bucket for 10 min. WT PDI plasmid was taken out from -20ºC and was thawed
too. 1 µl of the plasmid was added into 100 µl BL21 cell tube, and was kept on Ice for 30 min.
# the amount of plasmid may vary depending on the concentration of plasmid and the
competitiveness of BL21.
Heat shock was given for 60 sec. at 42ºC. (Isotemp should be pre-equilibrated).Then the cell was
Put it back on ice for 2 min. (meanwhile, prepare 1 ml LB in a 15 ml Falcon tube). 100 µl
transformed BL21was transferred to the 1 ml LB, and kept in 37ºC incubator with shaking at 150
rpm for 45 min. (meanwhile, LB-Amp plate was taken out from 4ºC and equilibrated to room
temp.) 100 µl of the LB (45 min incubated 1 ml LB) was spread onto the LB-Amp plate. The
LB/AMP plate was Incubated at 37ºC for 13 hrs. (It may vary ± 2hrs).After overnight incubation,
next day, a single colony was picked up into 50ml LB and add 0.1 ml of Ampicillin(Stock
concentration is 50 mg/ml and final concentration
in 50 ml LB is 0.1 mg/ml) in 250 ml
52
Erlenmeyer flask, and incubate at 37ºC with shaking at 150 rpm until OD600 reaches 0.5. Starter
culture O.D should not be allowed to exceed 0.5.
•

It will take ≈ 4hr. Check OD600 after 3 hr.

•

OD doubles, generally in 20 min.

25 ml of the starter culture was incubated into 1 L LB and add 2 ml of ampicillin stock was
added, and Incubated until OD600 reaches 0.55-0.6.
•

It will take ≈ 3-4 hrs.
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When the OD600 reaches 0.55-0.6, 1 ml of IPTG (0.5 M) was added, and it was shaken 4 more
hours. Then, ells were harvested by centrifuging at 5,000 rpm for 10 min at 4 OC. Supernatant
was discarded and resuspended with lysis buffer (No more than 20 ml).
Lysis buffer: 300 mM NaCl, 50 mM PO4, and 10 mM Imidazole, pH 7.5
Resuspended cells were placed in 50 ml Falcon Tube and were sonicated. The condition must be
set up with each machine.
# Four times 30-sec-sonications and 1 min cooling between each sonication.
# Sonication must be done in Ice-Bucket.
Then the cells were centrifuged at 11,000 rpm for 40 min at 4OC. Supernatant was taken and the
pellet was discarded. The supernatant was poured onto Ni-NTA resin in column and purified.

1

2

3

L

↓55K

←50KD

←40KD
←30KD

←15KD

Fig.25. Wild type PDI in SDS gel. L- ladder, 1-First wash (300 mM NaCl, 50 mM PO4, and 50
mM Imidazole, pH 7.5), 2- Second wash (300 mM NaCl, 50 mM PO4, and 100 mM Imidazole,
pH 7.5), and 3- Third wash (300 mM NaCl, 50 mM PO4, and 300 mM Imidazole, pH 7.5). PDI
protein came out as 55 KD molecular weight
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Fig.26. Experion gel picture for wild type PDI shows molecular weight of wild type PDI is 55KD

Fig.27. SDS gel pic which
shows RNaseA with its 13.4KD
molecular weight

↓13.4KD

←20KD

←10KD

←5KD
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Preparation of Fully Reduced RNase A. Purified native RNase A was reduced by
incubating the protein in a buffer containing 100 mM DTTred and 6 M GnHCl (100 mM TrisHCl, 1 mM EDTA, pH 8.3, 25 °C). After incubation for 3h, the pH of the solution was lowered
to 3 by addition of glacial acetic acid. The reduced protein was desalted (and DTTred was
removed) on a reversed-phase HPLC column (C-18) and lyophilized to remove the organic
solvent and water. Lyophilized reduced protein was dissolved in a dilute acetic acid solution (1µl
of glacial acetic acid with 100 ml of mili Q, pH 3.7) to obtain a stock solution (5.0 mg/mL) and
was stored at -20 °C.

OxidatiVe Folding of RNase A. Oxidative folding of RNaseA was carried out at 25 ºC in
four different test tubes with different reagents by incubating 0.5 mg/mL (33 µM) reduced
protein in a oxidizing buffer of 100 mM DTTox (pH 8.3, 100 mM Tris-HCl, 1 mM EDTA).
Number one test tube contains RNaseA (Final conc. 30µM) and oxidizing buffer. In second test
tube RNaseA (Final conc 30µM) added with oxidizing buffer and PDI (Final conc. 6µM).In the
next one we added RNaseA (Final conc.30µM), oxidizing buffer, PDI (Final conc. 6µM) and
Tetranitromethane (TNM, Final conc.360µM). In the last test tube we added RNaseA (Final
conc. 30µM), oxidizing buffer, PDI (Final conc. 6µM), masoprocol (Final conc. 720µM) and
Tetranitromethane (Final conc. 720µM). No DTTred was present in the original oxidation buffer,
but DTTred accumulated during the oxidation reaction. Aliquots of 200 µL were withdrawn at
different times after the initiation of oxidative folding, and any free thiols were blocked by an
excess amount of AEMTS (final concentration of 50 mM, pH 8.3, 100 mM Tris-HCl and 1 mM
EDTA). Five minutes after the addition of the AEMTS, the pH of the solution was lowered to 3
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by addition of 20 µL of glacial acetic acid. All samples were desalted on a Hi-Trap G25 column
by exchange against a 0.2% acetic acid solution before analysis using cation-exchange HPLC.
Prior to the addition of AEMTS which blocks any free thiols, some samples were subjected to a
reduction pulse (5 mM DTTred at pH 8.3 for 2 min) which results in the reduction of all
unstructured species to the fully reduced protein (R), a procedure that has been used successfully
to identify and isolate structured species in the oxidative folding of RNaseA. [95]

Results and Discussion
Results
Regeneration of RNase A. Fig.28 shows a typical HPLC chromatogram 60 min after initiation of
oxidative folding (100 mM DTTox, pH 8.3, 25 °C), and blocked with AEMTS. The native
protein (N), the 3S, 2S, and 1S ensembles, and the fully reduced protein (R) are clearly visible.

Fig.28. Regeneration of RNaseaA in HPLC

The table (7) below is the typical calculation formula for calculation of fraction of reduced and
native protein. Results from these experiments showed that the rate of formation of the native
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protein (N) which is indicated by Ln (1-n) where (1 – n) is the fractional concentration of nonnative RNaseA. Ti, T2 and so on are the different time points where 200µl of aliquots were
withdrawn. Times are calculated in minutes and each aliquot was withdrawn at 20 minutes
interval. All four experiments were started with fully reduced (R) RNaseA, as the time increases
RNaseA gradually become folded and as a result native (N) fraction of RNaseA increases with
time. In HPLC chromatogram two peaks are visible, one for reduced protein and another for
native protein. As the protein enrich by native fraction the hydrophobic part goes in the core of
the protein, unlikely, in the reduced protein hydrophobic portion will be exposed outside of the
amino acid chain, which leads the native peak to come before the reduced one because our
HPLC column has long hydrocarbon (C18) chain which is very strong hydrophobic. As the
reduced protein has exposed hydrophobic part it binds strongly with the column comparing to the
native protein and stick to the column for a longer time than the native protein and as a
consequence the reduced protein comes after the native one. With the help of area calculator, we
can calculate the area of reduced (R) RNaseA and the area of native (N) RNaseA. Once we get
all the Reduced and Native area at different time interval we can calculate the formation of
native fraction of RNaseA by the following calculation.

57

Table7.
Time Time(mins)
Point

Native(N)

reduced®

N+R

N/N+R

(1-n)

Ln(1-n)

T1

40

N1

R1

X1

Y1

Z1

F1

T2

60

N2

R2

X2

Y2

Z2

F2

T3

80

N3

R3

X3

Y3

Z3

F3

T4

100

N4

R4

X4

Y4

Z4

F4

T5

120

N5

R5

X5

Y5

Z5

F5

T6

140

N6

R6

X6

Y6

Z6

F6

T7

160

N7

R7

X7

Y7

Z7

F7

T8

180

N8

R8

X8

Y8

Z8

F8

T9

200

N9

R9

X9

Y9

Z9

F9

T10

220

N10

R10

X10

Y10

Z10

F10

T11

240

N11

R11

X11

Y11

Z11

F11

Experiment 1: first test tube contains RNaseA (Final conc. 30µM) and oxidizing buffer.
Table (8) below comprises all the data we have from HPLC.

Table8.
Time
point
T1
T2
T3
T4
T5
T6
T7
T8
T9

Time
(Mins)
40
60
80
100
120
140
160
180
200

Native
(N)
1.7
29.23
62.24
81
81.9
104.8
104.1
110.2
76.6

Reduced
(R)
105.3
382.44
722.4
908.47
858
881
781
781.34
458.9
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N+R
107
411.67
784.64
989.47
939.9
985.8
885.1
891.6
535.5

N/N+R
(n)
0.0159
0.071
0.0793
0.082
0.0871
0.1063
0.1176
0.1236
0.143

(1-n)

Ln(1-n)

0.9841
0.929
0.9207
0.918
0.913
0.8937
0.8824
0.8764
0.857

-0.016
-0.0736
-0.0826
-0.0856
-0.091
-0.1124
-0.1251
-0.1319
-0.1543

After we calculated native fraction (ln (1-n)) at different time interval we plotted the data in
excel and we get a figure like below.

RNaseA+Oxidizing buffer

Fig.29. gives us different native fractions at different time points when oxidative folding of
RNaseA is done with only oxidizing buffer. We added a trend line through the curve we get from
different data point. It gives us a straight line equation (Y= mX + C), where m is the slope of the
straight line.
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Experiment 2: second test tube contains RNaseA (Final conc 30µM) added with oxidizing
buffer and PDI (Final conc. 6µM). Table (9) below comprises all the data we have from HPLC.
Table9
Time
point
T2
T3
T4
T5
T6
T7
T8
T9
T10
T11

Time
(Mins)
40
60
80
100
120
140
160
180
200
220

Native
(N)
29.7
40.75
65.3
73.6
87.1
111.5
127.73
160.4
163.3
149.5

Reduced
(R)
339
340
292.5
287.84
286.44
256.3
287.56
309.4
304.67
286.1

N+R
368.7
380.75
357.8
361.44
373.5
367.8
415.29
469.8
467.97
335.6

From table9 we get the following figure

RNaseA+Oxidizing buffer+PDI

60

N/N+R
(n)
0.0855
0.107
0.1825
0.2036
0.2331
0.3031
0.3075
0.3414
0.3491
0.4204

(1-n)

Ln(1-n)

0.9145
0.893
0.8175
0.7964
0.7669
0.6969
0.6925
0.6586
0.6509
0.5796

-0.0894
-0.1132
-0.2015
-0.2277
-0.2714
-0.3611
-0.3674
-0.4176
-0.4294
-0.5454

Fig.30. gives us different native fractions at different time points when oxidative folding of
RNaseA is done with oxidizing buffer and PDI (Final conc. 6µM).We added a trend line through
the curve we get from different data point. It gives us a straight line equation (Y= mX + C),
where m is the slope of the straight line.

Experiment 3: Third test tube contains RNaseA (Final conc.30µM), oxidizing buffer, PDI
(Final conc. 6µM) and Tetranitromethane (TNM, Final conc.360µM). Table (10) below
comprises all the data we have from HPLC.

Table10.
Time
point
T2
T3
T4
T5
T6

Time
(Mins)

Native
(N)

Reduced
(R)

N+R

N/N+R
(n)

(1-n)

Ln(1-n)

40

13.7

728.3

742

0.0185

0.9815

-0.0187

60

24.7

829.1

853.8

0.0289

0.9711

-0.0293

80

21

550

571

0.0368

0.9632

-0.0375

100

30

544

574

0.0523

0.9477

-0.0537

120

32.9

589

621.9

0.053

0.947

-0.0544

140

41.3

680

721.3

0.0573

0.9427

-0.059

160

28.3

461.9

490.2

0.0577

0.9423

-0.0594

180

38.3

540.1

578.4

0.0662

0.9338

-0.0685

220

10.6

146.1

156.7

0.0676

0.9324

-0.0699

T7
T8
T9
T11

From table10 we get the following figure
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Fig.31. gives us different native fractions at different time points when oxidative folding of
RNaseA is done with oxidizing buffer, PDI (Final conc. 6µM) and Tetranitromethane (TNM,
Final conc.360µM). We added a trend line through the curve we get from different data point. It
gives us a straight line equation (Y= mX + C), where m is the slope of the straight line.

Experiment 4: Final test tube contains RNaseA (Final conc. 30µM), oxidizing buffer, PDI
(Final conc. 6µM), masoprocol (Final conc. 720µM0 and Tetranitromethane (Final conc.
720µM). Table (11) below comprises all the data we have from HPLC.
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Table11.
Time
point
T2
T3
T4
T5
T6
T7
T8
T9
T10
T11

Time
(Mins)
40
60
80
100
120
140
160
180
200
220

Native
(N)
6.74
16.7
20.6
23.8
23.97
27.97
25.4
25.9
27.7
36.4

Reduced
(R)
108
126
127.9
129.8
91.6
90.7
67.58
65.5
60.5
62.1

N+R
114.74
142.7
148.5
153.6
115.57
119.67
92.98
91.5
88.2
98.5

N/N+R
(n)
0.0587
0.117
0.1387
0.1549
0.2074
0.2337
0.2732
0.2831
0.3141
0.3695

(1-n)

Ln(1-n)

0.9413
0.883
0.8613
0.8451
0.7926
0.7663
0.7268
0.7169
0.6859
0.6305

-0.0605
-0.1244
-0.1493
-0.1683
-0.2324
-0.2662
-0.319
-0.3328
-0.377
-0.4612

From table5 we get the following figure

Fig.32. gives us different native fractions at different time points when oxidative folding of
RNaseA is done with oxidizing buffer, PDI (Final conc. 6µM), masoprocol (Final conc. 720µM)
and Tetranitromethane (TNM, Final conc.360µM). We added a trend line through the curve we
get from different data point. It gives us a straight line equation (Y= mX + C), where m is the
slope of the straight line.
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Blue line: RNaseA+Oxidizing buffer

Redline: RNaseA+Oxidizing
buffer+WT PDI

Green line: RNaseA+Oxidizing
buffer+WT PDI+TNM

Violet line: RNaseA+Oxidizing
buffer+WT PDI+Masoprocol+TNM

Fig.33. Folding rate from all above 4 experiments together

Table.12. Rate constant from above 4 experiment together
Reaction

Rate constant (Mmin)-1

Ratio

Uncatalyzed

6.0X10^-4

1

Catalyzed with WT PDI

23.0X10^-4

3.83

Catalyzed with WT PDI in the
presence of TNM

4.0X10^-4

0.67

Catalyzed with WT PDI in the
presence of masoprocol and
TNM

22.0X10^-4

3.67
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Discussion
In all above graphs we get protein folding curves which are been formed by different native
fractions in respect to different time. Every curve has a straight line equation with a specific
slope (m). This “m” indicates rate of protein folding. Slope for all 4 figures are 0.0006, 0.0023,
0.0004 and 0.0022 respectively. Number 28 and number 30 figures show very low and mostly
close “m” values where as, number 29 and number 31 figures show very high and very close “m”
values to each other as well. Figure number 28 produced from those data which we get when
oxidative folding of RNaseA performed with oxidizing buffer only. In absence of chaperone
protein PDI, RNaseA folding rate is very low. Figure number 29 is generated from those data
which we obtained from folding of RNaseA with oxidizing buffer and chaperone protein PDI.
The slope “m” is almost 4 times greater than the slope of number 28 figure, which interprets
effects of chaperone protein PDI on RNaseA folding; PDI increases the folding rate at significant
ratio. Slope of figure 30 is again very low and very close to figure 28. Figure 30 is derived from
data generated from RNaseA folding with oxidizing buffer, PDI and Tetranitromethane (TNM),
the NO donor. That means acceleration of protein folding by chaperone protein PDI disappeared
and folding likely depend on oxidizing buffer only rather PDI. Most of PDI activities are blocked
by nitro group donated by TNM. Thiol groups (SH-) are blocked by NO- and become SNO-, this
process is known as S-nitrosylation of PDI where PDI lose its catalytic and chaperon activity
resulting increased amount of misfolded protein in cell. These misfolded proteins aggregated in
ER and generates ER stress as a result neuronal cells are damaged which leads to
neurodegenerative diseases like Parkinson’s, Alzheimer’s, etc.
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Slope of figure number 31 is again very high and very close to figure number 29 which typically
shows regeneration of protein folding which was lost when PDI was blocked by nitro group of
TNM. After adding masoprocol with PDI protein folding rate is recovered which means that
masoprocol can scavenge nitro group from TNM instead of PDI get nitrated by nitro group. This
result also support the fact that masoprocol has much greater affinity towards nitro group than
PDI. By having better competency masoprocol can scavenge the nitro group to prevent PDI from
S-nitrosylation. Thus PDI still remains with its typical catalytic and chaperone activity and
accelerate protein folding to a certain rate which increases the fraction of native protein in short
period of time. By accelerating protein folding PDI prevents protein misfolding which means no
aggregation of misfolded protein, no inclusion or Lewy’s Body formation. As there is no

Rel. Rateof RNaseAregener.

inclusion body, no ER stress which leads no neuronal cell death.

120
90
60
30
0
cntrl
(no
PDI)

PDI

PDI +
NO

PDI +
curc.,
then
NO

Fig.34. shows that when PDI is added to substrate protein the rate of folding is increasing a
certain amount and when TNM (nitro group donor) is added to PDI, PDI is getting nitrated and
there is SNO-PDI formation which blocks PDI’s catalytic activity and certainly the rate of
folding is decreasing a certain amount. Again, when we are adding TNM with a mixture of small
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molecule and PDI the folding rate is increasing a certain amount as the folding rate of substrate
protein with PDI. That means, PDI activity is expressed here. The nitro groups are scavenged by
small molecule and PDI is not getting blocked by nitro group.

Conclusion
These studies concerning the influence of nitro group on S-nitrosylation of PDI and influence of
masoprocol on protection of PDI from S-nitrosylation. From all the above mentioned theoretical
information and lab experimental data we can conclude with two very important facts which are
very important in neurodegenerative diseases studies and for their prophylactic measurement. As
our first conclusion, UV spectrometer investigations suggest that masoprocol gets nitrated in the
presence of nitro group and mass spec investigations support the fact that curcumin gets nitrated
in the presence of nitro group. Second conclusion is even much more imperative in
neurodegenerative diseases studies. Oxidative folding experiments of RNaseA suggest the
underlying cause of S-nitrosylation of PDI and protection of S-nitrosylation by masoprocol as
well. Preventing S-nitrosylation of PDI by getting nitrated small molecules like, masoprocol
plays a crucial role in the circuit of neurodegenerative diseases.
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Chapter 4
Curcumin has a novel prophylactic action to protect protein from hydroxyl
stress
Introduction
Curcumin, the principle curcuminoids found in turmeric, and is generally considered its most
active constituent. We already discussed about the background information of curcumin and its
property of getting nitrated by free nitro group. Here, we tried a different experiment to
emphasize on curcumin’s hydroxyl group scavenging property. The protective effects of
curcumin against oxidative protein damage to free thiol containing protein, such as, β-lacto
globulin, treated with fenton reaction (hydroperoxide (H2O2) reacts with FeSO4to produce free
hydroxyl group) is studied in vitro. [96] We also investigated the effects of curcumin on the level
of total free thiol groups and low-molecular-weight thiols (glutathione and homocysteine) in βlacto globulin treated with free hydroxyl (OH) group. The defense mechanisms against oxidative
stress (free hydroxyl radical action) are very important for biological activities of cell. Moreover,
the role of exogenous antioxidants in the defense against oxidative stress in cell is still unknown.
Therefore, the protective effects of curcumin against the oxidative damage of free thiol
containing proteins and low molecular- weight thiols (glutathione and HCSH as important
components of redox thiol status) induced by free OH radicals were studied. Low molecular
weight thiols and disulfides, including GSH, Cys, and HCys, are critical cellular components that
play numerous important roles in metabolism and homeostasis. GSH, the most abundant nonprotein thiol, has many wide-ranging functions within the cell including detoxification of free
radicals and peroxides, regulation of cell growth and protein function, and
maintenance of immune function.[97] Cys also plays numerous important roles as a key
extracellular reducing agent, critical substrate for protein synthesis, and rate-limiting precursor
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for GSH and taurine synthesis. HCys is a critical regulatory intermediate of the Met cycle that
serves as a precursor for Cys via the transsulfuration pathway as well as for Met through
remethylation. Thiols group of GSH, Cys and HCys maintain the nerve cell active by formation
of di-sulfide bond. Free thiols always take a considerable account in neurodegenerative diseases,
like Alzheimer’s, Parkinson’s, etc. In these cases free thiols are blocked by free radical, like NO,
OH and form misfolded protein aggregation which disturbs the homeostasis. This underlying
cause leads us to study the mechanism of curcumin on free hydroxyl radical (OH). [98][99]

MATERIALS AND METHODS
Materials:
β-lacto globulin, a free thiol containing protein was purchased from sigma. Molecular weight of
this protein is 13.8 KD
Curcumin, H2O2, and FeSO4 were also brought from sigma.
Diluted acetic acid solution was prepared by diluting glacial acetic acid in milliQ water (500ml
milliQ water is added with 500µl of glacial acetic acid). A buffer solution is prepared to perform
fenton reaction (20mM tris HCL, 1mM EDTA, pH7)
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Methods:
10 mM β-lacto globulin solution was prepared with diluted acetic acid solution. Fenton reaction
is done in five different test tubes with five different concentration of H2O2, like 20µl, 30µl,
40µl, 50µl and 60µl with same amount of FeSO4 each time. 4mM curcumin solution was
prepared in acetonitrile. We took 60µl of protein solution in five test tubes and to it 50µl solution
was added from five different fenton reactions. In another five test tubes, we took 60µl of protein
in each test tube; 80µl of curcumin solution was added to each test tube which follows 50µl
solution of five different fenton reactions in five consecutive tubes. Two test tubes contain only
20ml 10 mM β-lacto globulin solution itself.

All these samples were prepared to run in 15% SDS (Sodium dodecyl sulphate) Page. Samples
were run in SDS at 110 V for 1hr 45 minutes. In one gel added protein itself and protein after
adding fenton reaction, where as in another gel we added protein itself and protein after adding
curcumin and fenton reaction.

70

Results and discussions:
Results
In our first gel, we loaded pure protein in the first lane and after that we loaded protein affected
by three different concentrations of fenton reactions. Figure below shows the result.

Fig.35. Shows β-lacto globulin at 13.8 KD size and protein is forming polymer after adding
fenton reaction, as the concentration of H2O2 increasing the amount of polymer is increasing as
well.
NB: lane 1, 2, 3 are protein with different concentrations (20, 30, 40, µlof H2O2)) of fenton
reaction. Lane 4 is for protein Ladder.

Above figure shows protein starts forming polymer and increasing as we increase the
concentration of H2O2 in fenton reaction. Hydroxyl radical production is consequently increased
as we increased the amount of H2O2.
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In our second gel, we loaded protein affected by curcumin and four different concentrations of
fenton reactions. Figure below shows the result.

Fig.36. Shows β-lacto globulin at 13.8 KD size. No polymer is found here.
NB: lane 1, 2, 3, 4, are protein with curcumin and different concentrations (20, 30, 40, 50 µlof
H2O2)) of fenton reaction. Lane 1and5 is for protein Ladder.

Above figure is showing that proteins are not forming polymer in the presence of sufficient
amount of curcumin, even, free hydroxyl radicals are there.
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Discussions
In recent years it has been an increasing interest in the fate of thiols in cell when free radicals are
produced. There are several technologies have been developed to observe this. However, there is
a critical and recognized need to see the polymer formation in SDS Page. In this study we
identified that the oxidative reactions are responsible to decrease the disulfide bond and results
increased amount of misfolded protein aggregation which leads to neurodegenerative diseases.
Fenton reaction is a potential index of oxidative reactions which produced free radicals like
hydroxyl (OH).
As we increased the concentration of H2O2 in fenton reaction OH concentration is also increased
at a subsequent rate. Fig.1 shows that as concentration of OH is increasing amount of protein
polymer is increasing as well. That means, free OH radicals are blocking free thiols of protein
and prevent the formation of disulfide bond which is imperative for thiol containing protein
folding. When thiols are getting blocked by hydroxyl radical protein amount of misfolded protein
will be increased which will aggregate and form inclusion body that leads to cell death and
ultimately numerous neurodegenerative diseases.
In our second experiment we used curcumin to study the prophylactic action of its on generated
free hydroxyl radicals. In presence of curcumin, proteins are not forming polymer, even in the
presence of hydroxyl free radicals. Fig.2 shows in the presence of curcumin and fenton reaction
proteins are not forming polymer, which typically proves free thiols are not getting hydroxylated
by free hydroxyl molecule; the OH radicals are generated and scavenged by curcumin as
curcumin gets ring and aliphatic chain hydroxylation. By scavenging the free hydroxyl radicals
curcumin assist to form disulfide bond by keeping free thiols intact.
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Conclusion
Our intensive study typically proves that curcumin has a prophylactic action to protect protein
from free hydroxyl stress. By preventing free thiols from free hydroxyl radical, eventually
curcumin takes a considerable account in protein folding and prevention of formation of
misfolded protein aggregation. Curcumin prevents the inclusion body formation which causes
stress in ER of the cell, and leads cell to die which is the obligatory cause for neurodegenerative
diseases.
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